| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/10/2007 | US20070105785 Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators |
| 05/10/2007 | US20070105784 Substituted quinolines for the treatment of cancer |
| 05/10/2007 | US20070105782 Protectant Combinations for Reducing Toxicities |
| 05/10/2007 | US20070105774 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
| 05/10/2007 | US20070105761 Methods, compositions, and kits for the treatment of opthalmic disorders |
| 05/10/2007 | US20070105753 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 05/10/2007 | US20070105752 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/10/2007 | US20070105751 Administering a NF- kappa B inhibitor in conjunction with the administration of a chemotherapeutic agent, whereby the cytotoxic effect of said chemotherapeutic agent is increased |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105151 Small molecule transcriptional activation domains |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070105142 Methods for prognosis and monitoring cancer therapy |
| 05/10/2007 | US20070105141 isolated cell having azetidinone cholesterol absorption inhibitor binded to the surface; measuring fluorescence; competitive binding assays; anticholesterol agents; as a tool for discovering proteins involved in absorption of cholesterol |
| 05/10/2007 | US20070105135 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/10/2007 | US20070104858 Process for extraction of beta-glucan from cereals and products obtained therefrom |
| 05/10/2007 | US20070104810 Agents for sequestering aging factors and uses thereof |
| 05/10/2007 | US20070104805 Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives |
| 05/10/2007 | US20070104804 Composition for treating cancer cells and preparation method for the same |
| 05/10/2007 | US20070104802 Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein |
| 05/10/2007 | US20070104801 Fertility and anti-aging supplement for the fertility health of females and males |
| 05/10/2007 | US20070104800 Compositions and methods for cancer treatment |
| 05/10/2007 | US20070104789 Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone |
| 05/10/2007 | US20070104787 Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances |
| 05/10/2007 | US20070104786 Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| 05/10/2007 | US20070104785 Tablets of linezolid form iii and processes for their preparation |
| 05/10/2007 | US20070104784 Compositions and methods of treatment comprising amoxicillin and potassium clavulante with xanthan |
| 05/10/2007 | US20070104783 Double-Layered Absorbable Solid Compositions for the Topical Treatment of Oral Mucosal Disorders |
| 05/10/2007 | US20070104782 Modified release tablet formulations with enhanced mechanical properties |
| 05/10/2007 | US20070104781 Hypocholesteremic preparations containing mixtures of phytostenol(ester)s and conjugated fatty acids, and methods of using the same |
| 05/10/2007 | US20070104780 Formulation comprising a drug of low water solubility and method of use thereof |
| 05/10/2007 | US20070104779 Treatment with omega-3 fatty acids and products thereof |
| 05/10/2007 | US20070104778 Controlled-release emulsion compositions |
| 05/10/2007 | US20070104777 Targeted liposomal drug delivery system |
| 05/10/2007 | US20070104776 Drug having regulatory cell ligand contained in liposome |
| 05/10/2007 | US20070104771 Transdermal galantamine delivery system |
| 05/10/2007 | US20070104770 Methods and Compositions For Topical Wound Treatment |
| 05/10/2007 | US20070104769 Bioabsorbable hemostatic gauze |
| 05/10/2007 | US20070104763 Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making |
| 05/10/2007 | US20070104760 Enteropathy ameliorating composition |
| 05/10/2007 | US20070104756 Obesity controlling method |
| 05/10/2007 | US20070104753 Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s) |
| 05/10/2007 | US20070104747 Cosmetic composition comprising at least one anti-dandruff agent and also oxyethylenated sorbitan monolaurate, and cosmetic treatment process using said composition |
| 05/10/2007 | US20070104746 Methods and compositions for reducing skin damage |
| 05/10/2007 | US20070104743 Formulations of fispemifene |
| 05/10/2007 | US20070104742 Novel oral formulations of ospemifene |
| 05/10/2007 | US20070104741 Delivery of tetrahydrocannabinol |
| 05/10/2007 | US20070104740 Self-microemulsifying drug delivery systems of a hiv protease inhibitor |
| 05/10/2007 | US20070104736 Culturing a non-typeable Haemophilus influenzae strain having a mutation in htrB gene, wherein the htrB mutation produces a mutant non-typeable Haemophilus influenzae; purifying the mutant endotoxin |
| 05/10/2007 | US20070104731 Helicobacter proteins and vaccines |
| 05/10/2007 | US20070104723 Treatment of fibrotic disease |
| 05/10/2007 | US20070104721 Antineoplastic combinations with mTOR inhibitor,herceptin, and/or hki-272 |
| 05/10/2007 | US20070104719 Caspase Activated Prodrugs Therapy |
| 05/10/2007 | US20070104714 Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axis |
| 05/10/2007 | US20070104711 Using tumor necrosis factor inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders |
| 05/10/2007 | US20070104700 Nutritional formula for optimal gut barrier function |
| 05/10/2007 | US20070104686 Vaccines, immunotherapeutics and methods for using the same |
| 05/10/2007 | US20070104683 Composition and methods for affecting metallocorrinoid uptake |
| 05/10/2007 | US20070104678 Ancient defense polymer |
| 05/10/2007 | US20070104677 Preparation in the form of an emulsion |
| 05/10/2007 | US20070104661 Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| 05/10/2007 | US20070104655 Inhalers used in the treatment of respiratory system disorders, such as chronic obstructive pulmonary disease and asthma |
| 05/10/2007 | US20070104654 For delivery of water insoluble drugs, growth factors, genes, or cosmetic substances; biocompatible and biodegradable |
| 05/10/2007 | US20070104652 Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin |
| 05/10/2007 | US20070104645 Chelate based scaffolds in tumor targeting |
| 05/10/2007 | US20070104644 Inhibitor imaging agents |
| 05/10/2007 | DE60119336T2 Verwendungen von thaliporphin oder seinen derivaten in der behandlung von herzkrankheiten und seine herstellung Uses of thaliporphine or its derivatives in the treatment of heart diseases and its production |
| 05/10/2007 | DE202007000181U1 Zubereitungen (Pharmazeutika, Desinfektionsmittel, Pflege- und Hygienemittel, Wundtherapeutika) mit Carvacrol, Shea Butter und Kieselsäure (Silica), in zweier oder dreier Kombinationen Preparations (pharmaceuticals, disinfectants, care and hygiene products, wound therapeutics) with carvacrol, shea butter and silica (silica), in two or three combinations |
| 05/10/2007 | DE202006018608U1 Buprenorphin-Wafer zur Drogensubstitutionstherapie Buprenorphine wafer for drug substitution therapy |
| 05/10/2007 | DE102006051391A1 Cosmetic and/or pharmaceutical composition, useful e.g. to treat aged skin and wrinkles, comprises e.g. lanolin, glycerin, urea, palmitoyl pentapeptide, vitamin-A and tocopherol derivatives, grape seed oil and coenzyme Q10 |
| 05/10/2007 | DE102006048362A1 Composition, useful to treat and/or protect disease condition e.g. circulatory disorder, comprises an active substance combination of isoflavone or isoflavone glycoside and a peptide derivative |
| 05/10/2007 | DE102005053771A1 Darreichform zur hormonalen Kontrazeption Darreichform for hormonal contraception |
| 05/10/2007 | DE102005003865A1 Oral composition, useful e.g. to enhance brain function, comprises phosphatidylserine and a flavor compound or its precursor |
| 05/10/2007 | CA2779041A1 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| 05/10/2007 | CA2632207A1 Use of calcitonin for the treatment of ra |
| 05/10/2007 | CA2628486A1 Tricyclo substituted amides |
| 05/10/2007 | CA2628477A1 Inhibition of autophagy genes in cancer chemotherapy |
| 05/10/2007 | CA2628474A1 Pyrimidinyl-thiophene kinase modulators |
| 05/10/2007 | CA2628414A1 Gastrointestinal function promoter |
| 05/10/2007 | CA2628300A1 Modified sirna molecules and uses thereof |
| 05/10/2007 | CA2628283A1 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 05/10/2007 | CA2628274A1 Glucokinase activators |
| 05/10/2007 | CA2628264A1 Aspartyl protease inhibitors |
| 05/10/2007 | CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2628225A1 A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof |
| 05/10/2007 | CA2628173A1 Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
| 05/10/2007 | CA2628089A1 Method of treating breast cancer |
| 05/10/2007 | CA2628026A1 Diazonamide a analog |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/10/2007 | CA2627934A1 Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage |
| 05/10/2007 | CA2627912A1 Treatment of diabetes |
| 05/10/2007 | CA2627910A1 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627892A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627875A1 Combinations comprising sorafenib and interferon for the treatment of cancer |
| 05/10/2007 | CA2627874A1 In vitro and in vivo anti-inflammatory effects of a sesquiterpene lactone extract from chicory (cichorium intybus l.) |
| 05/10/2007 | CA2627873A1 Treatment of cancer with sorafenib |
| 05/10/2007 | CA2627821A1 Vancomycin formulations having reduced amount of histamine |
| 05/10/2007 | CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627779A1 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1h-[1,8]naphthyridin-2-one |
| 05/10/2007 | CA2627759A1 Phenylenebisoxazolidine derivatives and their use as anticoagulants |
| 05/10/2007 | CA2627673A1 Kinase inhibitors |